Ifosfamide. Metabolic Studies, New Therapeutic Approaches and New Analogs

Konrad      Misiura

doi:10.2174/138955706776361385

Abstract

Ifosfamide (IFO), an oxazaphosphorine-type anticancer alkylating agent, was found to be particularly useful in the treatment of a wide variety of neoplasm in adults and children. IFO is a positional

Keywords: Ifosfamide, Cyclophosphamide, Bromofosfamide, Oxazaphosphorine drugs

« Previous Next »

Rights & Permissions Print Cite

Mini-Reviews in Medicinal Chemistry

Title: Ifosfamide. Metabolic Studies, New Therapeutic Approaches and New Analogs

Volume: 6 Issue: 4

Author(s): Konrad Misiura

Affiliation:

Keywords: Ifosfamide, Cyclophosphamide, Bromofosfamide, Oxazaphosphorine drugs

Abstract: Ifosfamide (IFO), an oxazaphosphorine-type anticancer alkylating agent, was found to be particularly useful in the treatment of a wide variety of neoplasm in adults and children. IFO is a positional

Export Options

Export File:

RIS (for EndNote, Reference Manager, ProCite)

BibTeX

Text

Content:

Citation Only

Citation and Abstract

About this article

Cite this article as:

Misiura Konrad, Ifosfamide. Metabolic Studies, New Therapeutic Approaches and New Analogs, Mini-Reviews in Medicinal Chemistry 2006; 6 (4) . https://dx.doi.org/10.2174/138955706776361385